Sarepta Therapeutics Inc (NASDAQ:SRPT) is down over 45% in pre-market trading following a negative vote by an FDA advisory panel regarding the effectiveness …
Healthcare analysts weigh in on biotech companies Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Sarepta Therapeutics Inc (NASDAQ:SRPT), as the stocks turned extremely volatile following recent news. …
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares sank in Thursday’s trading session after the FDA released negative briefing documents regarding the company’s Duchenne muscular dystrophy …
Tuesday turned out to be a nightmare for shareholders of drug maker Sarepta Therapeutics Inc (NASDAQ:SRPT) and surgical robot maker Transenterix Inc (NYSEMKT:TRXC), as the stock …
Transenterix Inc (NYSEMKT:TRXC) is down a whopping 65% in pre-market trading after the FDA determined that its SurgiBot system does not adequately meet …
Healthcare analysts commented on positive study data from biopharma companies Galena Biopharma Inc (NASDAQ:GALE) and Sarepta Therapeutics Inc (NASDAQ:SRPT). Both analysts believe the …
Healthcare analysts weighed in on pharmaceutical companies Sarepta Therapeutics (NASDAQ:SRPT), and Relypsa Inc (NASDAQ:RLYP). With Sarepta approaching an FDA advisory committee meeting, and Relypsa facing an issue regarding …
In a research report published Wednesday, Oppenheimer’s healthcare analyst Christopher Marai reiterated an Outperform rating on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), while raising the price target …
Linn Energy LLC (NASDAQ:LINE) is down over 20% in pre-market trading after announcing that it has entered into a settlement agreement with some of …
Moving a pipeline drug from inception to commercialization can take years for biotech companies. Analysts weigh in on upcoming catalysts for Sarepta Therapeutics …
